Capha Pharmaceuticals Inc. filed its Annual on Apr 26, 2023 for the period ending Dec 31, 2022. In this report its auditor, Dyke & Howard - D & H Group LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 64 | |
+25.83% | 661B | |
+27.17% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.53% | 231B | |
+5.01% | 200B | |
-9.16% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- FPSUF Stock
- News Capha Pharmaceuticals Inc.
- Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt